Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS2R14 | Q9NYV8 | 12/20 | 0.59 |
| ▸ | CXCR3 | P49682 | 2/20 | 0.59 |
| ▸ | PTGES | O14684 | 1/20 | 0.59 |
| ▸ | TAS2R8 | Q9NYW2 | 1/20 | 0.59 |
| ▸ | BMP1 | P13497 | 1/20 | 0.57 |
| ▸ | BACE1 | P56817 | 2/20 | 0.55 |
| ▸ | RORC | P51449 | 1/20 | 0.53 |
| ▸ | CNR1 | P21554 | 1/20 | 0.53 |
| ▸ | CNR2 | P34972 | 1/20 | 0.53 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6321716 | 0.87 | TAS2R14 (0.61) | TAS2R14CXCR3PTGESTAS2R8BMP1 | |
| SCHEMBL6323899 | 0.84 | TAS2R14 (0.58) | TAS2R14CXCR3PTGESTAS2R8BMP1 | |
| SCHEMBL6324161 | 0.82 | TAS2R14 (0.66) | TAS2R14CXCR3PTGESTAS2R8BMP1 | |
| SCHEMBL9287153 | 0.81 | RORC (0.68) | TAS2R14CXCR3PTGESTAS2R8BMP1 | |
| SCHEMBL6323932 | 0.79 | TAS2R14 (0.62) | TAS2R14CXCR3PTGESTAS2R8BMP1 | |
| SCHEMBL28729777 | 0.79 | TAS2R14 (0.80) | TAS2R14CXCR3PTGESTAS2R8BMP1 | |
| SCHEMBL7343981 | 0.77 | BMP1 (0.77) | TAS2R14CXCR3PTGESTAS2R8BMP1 | |
| SCHEMBL5092519 | 0.77 | KEAP1 (0.81) | TAS2R14CXCR3PTGESTAS2R8BMP1 | |
| SCHEMBL1615406 | 0.75 | TAS2R14 (0.74) | TAS2R14CXCR3PTGESTAS2R8BMP1 | |
| SCHEMBL1169926 | 0.75 | TAS2R14 (1.00) | TAS2R14CXCR3PTGESTAS2R8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1986657-A2 | METHOD OF TREATING A SUBJECT SUFFERING FROM DEGENERATIVE DISC DISEASE USING A MATRIX METALLOPROTEASE INHIBITOR | Discogen, LLC (US) | 2008-11-05 | — | — | EP | disclosed |
| WO-2007098099-A2 | METHOD OF TREATING A SUBJECT SUFFERING FROM DEGENERATIVE DISC DISEASE USING A MATRIX METALLOPROTEASE INHIBITOR | DISCOGEN, LLC (US) | 2007-08-30 | — | — | WO | disclosed |
| EP-1028716-A1 | METHOD FOR TREATING AND PREVENTING HEART FAILURE AND VENTRICULAR DILATATION | WARNER-LAMBERT COMPANY (US) | 2000-08-23 | — | — | EP | disclosed |
| WO-1998025597-A2 | METHOD FOR TREATING AND PREVENTING HEART FAILURE AND VENTRICULAR DILATATION | WARNER-LAMBERT COMPANY (US) | 1998-06-18 | — | — | WO | disclosed |